
Disclaimer: This podcast is not sponsored by or associated with any of the products mentioned in today's episode.
In this episode of Skinfluenced: The Skin Podcast, we’re shining a spotlight on Chronic Hand Eczema (CHE). With the recent approval the first topical treatment for moderate to severe chronic hand eczema, we want to brush everyone up on CHE.
Tune in to discover how this new medication, a topical Janus kinase (JAK) inhibitor, performs against placebo in improving chronic hand eczema. We discuss the clinical benefits, safety profile, and what this means for patients struggling with persistent hand eczema despite conventional therapies.
Link to Source(s):
Mense SA, Maher S, & Chovatiya RA. A Practical Approach to Chronic Hand Eczema: https://rdcu.be/ey3d5
#ChronicHandEczema #CHE #Delgocitinib #JAKInhibitor #HandDermatitis #FDAApproval #InflammatorySkinDisease #TopicalJAKInhibitor #OccupationalEczema #SkinBarrierRepair #SkinScience #Dermatology #DermatologyProvider #Dermatologist #CosmeticDermatology #Aesthetics #PhysicianAssistant #PhysicianAssociate #NursePractitioner #DermatologyPodcast #SkinfluencedPodcast